BioMérieux Buys Argene for up to $60.1M

BioMérieux plans to migrate Argene's test products onto a molecular diagnostic platform it is co-developing with Biocartis.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories